Ehrlich Christopher B

CIK 000129397310 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001293973

Recent Transactions

50 trades

Award
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Stock Option (Right to Buy)
2026-01-07+4,530,997→ 4,530,997 total
Award
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Stock Option (Right to Buy)
2025-05-30+61,843→ 61,842 total
Award
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Stock Option (Right to Buy)
2025-03-04+119,486→ 119,486 total
Award
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Stock Option (Right to Buy)
2025-02-24+1,275,000→ 2,550,000 total
Award
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Stock Option (Right to Buy)
2024-12-02+1,275,000→ 1,275,000 total
Disposition to Issuer
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Stock Option (Right to Buy)
2024-09-30−572,182→ 0 total
Exercise/Conversion
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Series A Convertible Preferred Stock
2024-09-25$1000.00/sh−275→ 0 total
Exercise/Conversion
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Common Stock
2024-09-25+5,312,983→ 5,791,808 total
Award
eFFECTOR Therapeutics, Inc.
Stock Option (Right to Buy)
2024-06-13+800→ 800 total
Award
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Stock Option (Right to Buy)
2024-03-25+572,182→ 572,182 total
Award
eFFECTOR Therapeutics, Inc.
Stock Option (Right to Buy)
2024-02-19+2,000→ 2,000 total
Exercise/Conversion
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Series A Convertible Preferred Stock
2024-02-14$1000.00/sh+1,555→ 1,555 total
Exercise/Conversion
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Convertible Promissory Note
2024-02-14−0→ 0 total
Other
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Common Stock
2024-02-14−4,171,246→ 1,000,000 total
Other
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Warrants
2024-02-14+5,000→ 5,000 total
Award
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Series A Convertible Preferred Stock
2024-02-14$1000.00/sh+100→ 100 total
Other
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Common Stock
2024-02-14+478,825→ 478,825 total
Other
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Series A Convertible Preferred Stock
2024-02-14$1000.00/sh+175→ 275 total
Other
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Common Stock
2024-02-14+3,600→ 3,600 total
Other
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Common Stock
2024-02-14−1,125,000→ 4,171,246 total
Other
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Warrants
2024-02-14−349,998→ 0 total
Other
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Series A Convertible Preferred Stock
2024-02-14$1000.00/sh−1,555→ 0 total
Award
eFFECTOR Therapeutics, Inc.
Stock Option (Right to Buy)
2023-06-22+20,000→ 20,000 total
Award
eFFECTOR Therapeutics, Inc.
Stock Option (Right to Buy)
2023-01-20+35,938→ 35,938 total
Purchase
eFFECTOR Therapeutics, Inc.
Common Stock
2022-10-04$0.57/sh+346→ 35,213 total
Purchase
eFFECTOR Therapeutics, Inc.
Common Stock
2022-09-26$0.55/sh+18,867→ 34,867 total
Award
eFFECTOR Therapeutics, Inc.
Stock Option (Right to Buy)
2022-06-09+20,000→ 20,000 total
Purchase
eFFECTOR Therapeutics, Inc.
Common Stock
2022-02-18$4.30/sh+1,000→ 16,000 total
Purchase
eFFECTOR Therapeutics, Inc.
Common Stock
2022-02-14$4.45/sh+2,000→ 15,000 total
Purchase
eFFECTOR Therapeutics, Inc.
Common Stock
2022-02-09$4.75/sh+1,000→ 13,000 total
Purchase
eFFECTOR Therapeutics, Inc.
Common Stock
2022-02-08$4.92/sh+1,000→ 12,000 total
Purchase
eFFECTOR Therapeutics, Inc.
Common Stock
2022-02-04$5.00/sh+1,000→ 11,000 total
Purchase
eFFECTOR Therapeutics, Inc.
Common Stock
2022-02-03$5.15/sh+5,000→ 10,000 total
Purchase
eFFECTOR Therapeutics, Inc.
Common Stock
2022-01-27$5.30/sh+5,000→ 5,000 total
Other
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Warrants
2021-10-08+18,366→ 349,998 total
Other
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Class B Common Stock
2021-10-08−82,875→ 4,596,250 total
Other
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Class A common stock
2021-10-08$10.00/sh+36,733→ 699,996 total
Award
eFFECTOR Therapeutics, Inc.
Stock Option (Right to Buy)
2021-10-06+40,000→ 40,000 total
Disposition to Issuer
eFFECTOR Therapeutics, Inc.
Class B Common Stock
2021-08-25−966→ 1,034 total
Conversion
eFFECTOR Therapeutics, Inc.
Common Stock
2021-08-25+142,168→ 142,168 total
Conversion
eFFECTOR Therapeutics, Inc.
Class B Common Stock
2021-08-25−142,168→ 0 total
Conversion
eFFECTOR Therapeutics, Inc.
Common Stock
2021-08-25+1,034→ 1,034 total
Disposition to Issuer
eFFECTOR Therapeutics, Inc.
Class B Common Stock
2021-08-25−132,832→ 142,168 total
Conversion
eFFECTOR Therapeutics, Inc.
Class B Common Stock
2021-08-25−1,034→ 0 total
Other
eFFECTOR Therapeutics, Inc.
Class B Common Stock
2021-01-12−23,750→ 4,511,250 total
Award
Paratek Pharmaceuticals, Inc.
Common Stock Option (right to buy)
2013-04-10+13,500→ 13,500 total
Disposition to Issuer
BIOMIMETIC THERAPEUTICS, INC.
Common Stock
2013-03-01−1,250→ 0 total
Disposition to Issuer
BIOMIMETIC THERAPEUTICS, INC.
Common Stock
2013-03-01−857,692→ 0 total
Disposition to Issuer
BIOMIMETIC THERAPEUTICS, INC.
Stock Option (right to buy)
2013-03-01−8,840→ 0 total
Disposition to Issuer
BIOMIMETIC THERAPEUTICS, INC.
Common Stock
2013-03-01−941,177→ 0 total

Companies

Recent Filings

Address

CERO THERAPEUTICS HOLDINGS, INC. 201 HASKINS WAY, SUITE 230

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov